Vaccine Adverse Event Reporting System - Vaccines

Relevant Publications

JYNNEOS vaccine safety surveillance during the 2022 mpox outbreak using the Vaccine Adverse Event Reporting System (VAERS) and v-safe, United States, 2022-2023.

Issue Release: 2024

Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021-2022.

Issue Release: 2024

Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review.

Issue Release: 2024

Reports of COVID-19 Vaccine Adverse Events in Predominantly Republican vs Democratic States.

Issue Release: 2024

Administration of the GSK Respiratory Syncytial Virus Vaccine to Pregnant Persons in Error.

Issue Release: 2024

Misinformation and the Vaccine Adverse Event Reporting System.

Issue Release: 2024

Adverse events following Measles-Mumps-Rubella and varicella immunization: A safety profile analysis and comparison of different vaccination schedules based on the Italian Pharmacovigilance Network in the Veneto Region.

Issue Release: 2024

Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.

Issue Release: 2024

Ophthalmologic Complications in Coronavirus Disease 2019 Immunization: A National Vaccine Adverse Event Reporting System Analysis.

Issue Release: 2024

Vaccination and clozapine use: a systematic review and an analysis of the VAERS database.

Issue Release: 2024

Improving large language models for clinical named entity recognition via prompt engineering.

Issue Release: 2024

Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis.

Issue Release: 2024

AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.

Issue Release: 2024

Short-Term Reported Urologic Adverse Events Following COVID-19 Immunization: A Vaccine Adverse Event Reporting System Analysis.

Issue Release: 2024

Incidence and Nature of Short-Term Adverse Events following COVID-19 Second Boosters: Insights from Taiwan\'s Universal Vaccination Strategy.

Issue Release: 2024

Safety signal detection with control of latent factors.

Issue Release: 2024

Risk of myocarditis after three doses of COVID-19 mRNA vaccines in the United States, 2020-2022: A self-controlled case series study.

Issue Release: 2024

A patient safety knowledge graph supporting vaccine product development.

Issue Release: 2024

Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.

Issue Release: 2024

Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023.

Issue Release: 2024

What is Case Detection Rate?

Who Should Get the Pneumococcal Vaccine?

What is the Future of Experimental Vaccines?

Are There Any Contraindications for the DTP Vaccine?

How can vaccine coverage be improved?

Is the Hepatitis B Vaccine Safe for Pregnant Women?

How are Recombinant Vaccines Made?

What Are the Recommendations for Breastfeeding Mothers?

How Long Does Preclinical Testing Take?

How Does VDPV Occur?

Partnered Content Networks

Relevant Topics